Priyanka Verma, PhD

Dr. Priyanka Verma is an Assistant Professor in the Division of Oncology, Department of Medicine at the Washington University, School of Medicine. She completed her Ph.D. in Biochemistry from the National Institute of Immunology, New Delhi, India. Dr. Verma pursued her postdoctoral training with Dr. Roger A Greenberg at the University of Pennsylvania where she was the recipient of an OCRA Ann and Sol Schreiber Mentored Investigator Award. Her OCRA supported research uncovered a PAR-dependent nucleosome sliding enzyme, ALC1 (Amplified in Liver Cancer 1), as a new drug target for BRCA-mutant ovarian cancers. Research in her independent group integrates several functional genomics tools to understand how PAR-dependent chromatin remodeling impacts ovarian cancer etiology and responses to targeted therapies. For her outstanding research contributions, Dr. Verma has been named as the Inaugural Pedal the Cause Researcher by Siteman Cancer Center. She has also received multiple accolades including the V-Scholar Grant, Rivkin Pilot study Grant and Mary Kay Ash Cancer Research Grant.